X. Fei

发表

An Analysis on the Clinical Features of MHD Patients with Coronavirus Disease 2019: A Single Center Study

Liu Haifeng, M. Dongdong, Cheng Li, 2020 .

PEGylated long-circulating liposomes deliver homoharringtonine to suppress multiple myeloma cancer stem cells

J. Dou, N. Gu, Fangfang Shi, 2017, Experimental biology and medicine.

Characterization, lung targeting profile and therapeutic efficiency of dipyridamole liposomes

C. Ji, Sheng-jun Chen, X. Fei, 2006, Journal of drug targeting.

A biodegradable multifunctional porous microsphere composed of carrageenan for promoting imageable trans-arterial chemoembolization.

Zhu Haidong, Huang Xiaolong, Jin Zhicheng, 2019, International journal of biological macromolecules.

Homoharringtonine delivered by high proportion PEG of long- circulating liposomes inhibits RPMI8226 multiple myeloma cells in vitro and in vivo.

J. Dou, N. Gu, Fangfang Shi, 2016, American journal of translational research.

Preparation, characterization, and biodistribution of breviscapine proliposomes in heart

Wang Hao, Gu Ning, X. Fei, 2009, Journal of drug targeting.

Preparation, characterization and pharmacokinetics of N‐palmitoyl chitosan anchored docetaxel liposomes

X. Fei, Ge Liang, Z. Jia-bi, 2007, The Journal of pharmacy and pharmacology.

Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent

Jia-bi Zhu, Gu Ning, X. Fei, 2010, Drug development and industrial pharmacy.

Hsa-miR-10a-5p promotes pancreatic cancer growth by BDNF/SEMA4C pathway.

X. Tan, L. Kong, Y. Gao, 2020, Journal of biological regulators and homeostatic agents.

Quality Evaluation of Breviscapine Pre-nanoliposome

X. Fei, 2004 .